Literature DB >> 23818614

Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels.

Ken McCormack1, Sonia Santos, Mark L Chapman, Douglas S Krafte, Brian E Marron, Christopher W West, Michael J Krambis, Brett M Antonio, Shannon G Zellmer, David Printzenhoff, Karen M Padilla, Zhixin Lin, P Kay Wagoner, Nigel A Swain, Paul A Stupple, Marcel de Groot, Richard P Butt, Neil A Castle.   

Abstract

Voltage-gated sodium (Nav) channels play a fundamental role in the generation and propagation of electrical impulses in excitable cells. Here we describe two unique structurally related nanomolar potent small molecule Nav channel inhibitors that exhibit up to 1,000-fold selectivity for human Nav1.3/Nav1.1 (ICA-121431, IC50, 19 nM) or Nav1.7 (PF-04856264, IC50, 28 nM) vs. other TTX-sensitive or resistant (i.e., Nav1.5) sodium channels. Using both chimeras and single point mutations, we demonstrate that this unique class of sodium channel inhibitor interacts with the S1-S4 voltage sensor segment of homologous Domain 4. Amino acid residues in the "extracellular" facing regions of the S2 and S3 transmembrane segments of Nav1.3 and Nav1.7 seem to be major determinants of Nav subtype selectivity and to confer differences in species sensitivity to these inhibitors. The unique interaction region on the Domain 4 voltage sensor segment is distinct from the structural domains forming the channel pore, as well as previously characterized interaction sites for other small molecule inhibitors, including local anesthetics and TTX. However, this interaction region does include at least one amino acid residue [E1559 (Nav1.3)/D1586 (Nav1.7)] that is important for Site 3 α-scorpion and anemone polypeptide toxin modulators of Nav channel inactivation. The present study provides a potential framework for identifying subtype selective small molecule sodium channel inhibitors targeting interaction sites away from the pore region.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23818614      PMCID: PMC3718154          DOI: 10.1073/pnas.1220844110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

Review 1.  The action potential: from voltage-gated conductances to molecular structures.

Authors:  Francisco Bezanilla
Journal:  Biol Res       Date:  2006-11-07       Impact factor: 5.612

Review 2.  Animal peptides targeting voltage-activated sodium channels.

Authors:  Bert Billen; Frank Bosmans; Jan Tytgat
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

Review 3.  Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders.

Authors:  Massimo Mantegazza; Giulia Curia; Giuseppe Biagini; David S Ragsdale; Massimo Avoli
Journal:  Lancet Neurol       Date:  2010-04       Impact factor: 44.182

Review 4.  Ion channel voltage sensors: structure, function, and pathophysiology.

Authors:  William A Catterall
Journal:  Neuron       Date:  2010-09-23       Impact factor: 17.173

5.  Mapping the receptor site for alpha-scorpion toxins on a Na+ channel voltage sensor.

Authors:  Jinti Wang; Vladimir Yarov-Yarovoy; Roy Kahn; Dalia Gordon; Michael Gurevitz; Todd Scheuer; William A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-29       Impact factor: 11.205

Review 6.  Sodium channel inhibiting marine toxins.

Authors:  Lyndon E Llewellyn
Journal:  Prog Mol Subcell Biol       Date:  2009

7.  Inhibition of sodium channel gating by trapping the domain II voltage sensor with protoxin II.

Authors:  Stanislav Sokolov; Richard L Kraus; Todd Scheuer; William A Catterall
Journal:  Mol Pharmacol       Date:  2007-12-21       Impact factor: 4.436

8.  ProTx-II, a selective inhibitor of NaV1.7 sodium channels, blocks action potential propagation in nociceptors.

Authors:  William A Schmalhofer; Jeffrey Calhoun; Rachel Burrows; Timothy Bailey; Martin G Kohler; Adam B Weinglass; Gregory J Kaczorowski; Maria L Garcia; Martin Koltzenburg; Birgit T Priest
Journal:  Mol Pharmacol       Date:  2008-08-26       Impact factor: 4.436

Review 9.  Voltage-gated sodium channel blockers; target validation and therapeutic potential.

Authors:  John N Wood; James Boorman
Journal:  Curr Top Med Chem       Date:  2005       Impact factor: 3.295

Review 10.  Conotoxins targeting neuronal voltage-gated sodium channel subtypes: potential analgesics?

Authors:  Oliver Knapp; Jeffrey R McArthur; David J Adams
Journal:  Toxins (Basel)       Date:  2012-11-08       Impact factor: 4.546

View more
  92 in total

Review 1.  Bacterial voltage-gated sodium channels (BacNa(V)s) from the soil, sea, and salt lakes enlighten molecular mechanisms of electrical signaling and pharmacology in the brain and heart.

Authors:  Jian Payandeh; Daniel L Minor
Journal:  J Mol Biol       Date:  2014-08-23       Impact factor: 5.469

2.  A monoclonal antibody that targets a NaV1.7 channel voltage sensor for pain and itch relief.

Authors:  Jun-Ho Lee; Chul-Kyu Park; Gang Chen; Qingjian Han; Rou-Gang Xie; Tong Liu; Ru-Rong Ji; Seok-Yong Lee
Journal:  Cell       Date:  2014-05-22       Impact factor: 41.582

Review 3.  [Neuropathic pain associated with Nav1.7 mutations: clinical picture and treatment].

Authors:  K Doppler; C Sommer
Journal:  Nervenarzt       Date:  2013-12       Impact factor: 1.214

4.  PF-06526290 can both enhance and inhibit conduction through voltage-gated sodium channels.

Authors:  Lingxin Wang; Shannon G Zellmer; David M Printzenhoff; Neil A Castle
Journal:  Br J Pharmacol       Date:  2018-06-03       Impact factor: 8.739

5.  Reporting sodium channel activity using calcium flux: pharmacological promiscuity of cardiac Nav1.5.

Authors:  Hongkang Zhang; Beiyan Zou; Fang Du; Kaiping Xu; Min Li
Journal:  Mol Pharmacol       Date:  2014-11-24       Impact factor: 4.436

Review 6.  Structural Basis for Pharmacology of Voltage-Gated Sodium and Calcium Channels.

Authors:  William A Catterall; Teresa M Swanson
Journal:  Mol Pharmacol       Date:  2015-04-06       Impact factor: 4.436

Review 7.  Na+ channel function, regulation, structure, trafficking and sequestration.

Authors:  Ye Chen-Izu; Robin M Shaw; Geoffrey S Pitt; Vladimir Yarov-Yarovoy; Jon T Sack; Hugues Abriel; Richard W Aldrich; Luiz Belardinelli; Mark B Cannell; William A Catterall; Walter J Chazin; Nipavan Chiamvimonvat; Isabelle Deschenes; Eleonora Grandi; Thomas J Hund; Leighton T Izu; Lars S Maier; Victor A Maltsev; Celine Marionneau; Peter J Mohler; Sridharan Rajamani; Randall L Rasmusson; Eric A Sobie; Colleen E Clancy; Donald M Bers
Journal:  J Physiol       Date:  2015-03-15       Impact factor: 5.182

8.  Pharmacology of the Nav1.1 domain IV voltage sensor reveals coupling between inactivation gating processes.

Authors:  Jeremiah D Osteen; Kevin Sampson; Vivek Iyer; David Julius; Frank Bosmans
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-12       Impact factor: 11.205

9.  GpTx-1 and [Ala5 , Phe6 , Leu26 , Arg28 ]GpTx-1, two peptide NaV 1.7 inhibitors: analgesic and tolerance properties at the spinal level.

Authors:  Chao Chen; Biao Xu; Xuerui Shi; Mengna Zhang; Qinqin Zhang; Ting Zhang; Weidong Zhao; Run Zhang; Zilong Wang; Ning Li; Quan Fang
Journal:  Br J Pharmacol       Date:  2018-09-09       Impact factor: 8.739

10.  Protein-Protein Interactions as New Targets for Ion Channel Drug Discovery.

Authors:  Svetla Stoilova-McPhie; Syed Ali; Fernanda Laezza
Journal:  Austin J Pharmacol Ther       Date:  2013-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.